quinazolines has been researched along with Protein Aggregation, Pathological in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiasseu, M; Chyung, A; Fesharaki-Zadeh, A; Luo, A; Nies, SH; Smith, LM; Strittmatter, SM; Takahashi, H; Tang, SJ | 1 |
| Kumar, R; Pavlov, PF; Wang, L; Winblad, B | 1 |
1 review(s) available for quinazolines and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.
Topics: Alzheimer Disease; Animals; Benzodioxoles; Cholinesterase Inhibitors; Cholinesterases; Curcumin; Humans; Molecular Targeted Therapy; Neurofibrillary Tangles; Neuroprotective Agents; Phosphorylation; Plaque, Amyloid; Protein Aggregation, Pathological; Protein Processing, Post-Translational; Quinazolines; Receptors, N-Methyl-D-Aspartate; tau Proteins; Thiadiazoles | 2021 |
1 other study(ies) available for quinazolines and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy.
Topics: Aged, 80 and over; Animals; Benzodioxoles; Brain Concussion; Enzyme Inhibitors; Humans; Male; Memory Disorders; Mice; Mice, Transgenic; Protein Aggregates; Protein Aggregation, Pathological; Proto-Oncogene Proteins c-fyn; Quinazolines; Synapses; tau Proteins; Tauopathies | 2020 |